| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.0033 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0061 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.003 | 1 |